Fosun Pharma seeks to expand its global sales by tapping merger and acquisition opportunities and launching innovative drugs in more overseas markets, CEO says in an interview. Read More
Fosun Pharma, BioNTech vaccine agent, eyes M&As in global expansion
2021-04-01T05:05:13-04:00April 1st, 2021|
Related Posts
-
HK-listed asset manager Value Partners Group CEO steps down
April 26th, 2024 -
PE firm Advent to invest $297m in India’s Apollo HealthCo
April 26th, 2024 -
Copper hits 2-year high above $10,000 on China squeeze
April 26th, 2024